Sulzgruber, P., Wassmann, S., Semb, A., Doehner, W., Widimsky, P., Gremmel, T., . . . Niessner, A. (2019). Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1. European heart journal. Cardiovascular pharmacotherapy, 5(3), 171. https://doi.org/10.1093/ehjcvp/pvz016
Chicago Style (17th ed.) CitationSulzgruber, P., et al. "Oral Anticoagulation in Patients with Non-valvular Atrial Fibrillation and a CHA2DS2-VASc Score of 1." European Heart Journal. Cardiovascular Pharmacotherapy 5, no. 3 (2019): 171. https://doi.org/10.1093/ehjcvp/pvz016.
MLA (9th ed.) CitationSulzgruber, P., et al. "Oral Anticoagulation in Patients with Non-valvular Atrial Fibrillation and a CHA2DS2-VASc Score of 1." European Heart Journal. Cardiovascular Pharmacotherapy, vol. 5, no. 3, 2019, p. 171, https://doi.org/10.1093/ehjcvp/pvz016.